OvaScience (OVAS) Tops Q3 EPS by 8c

OvaScience (NASDAQ: OVAS) reported Q3 EPS of ($0.54), $0.08 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $197 thousand versus the consensus estimate of $200 thousand.

As of September 30, 2016, OvaScience had cash, cash equivalents, and short-term investments of $131.0 million, compared to $126.7 million on December 31, 2015. The increase reflects the net proceeds of $53.9 million received from the completion of OvaScience’s follow-on offering in the second quarter of 2016.

For earnings history and earnings-related data on OvaScience (OVAS) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• zSpace, Inc. (ZSPC) Reports Q2 results
• Eikon Therapeutics, Inc. (EIKN) Misses Q2 EPS by 163c